Gambaran Pelaksanaan Deteksi Dini Dan Respon Pandemi COVID-19 Di Dinas Kesehatan Kabupaten Pamekasan
Downloads
ABSTRAK
Latar Belakang: Penyakit coronavirus merupakan penyakit baru yang muncul pertama kali di Wuhan, Cina. Kasus menyebar hingga menginfeksi lebih dari 13 juta jiwa sampai 13 Juli 2020. Kasus COVID-19 pertama kali dilaporkan di Kabupaten Pamekasan pada 29 Maret 2020. Kasus terus mengalami peningkatan dan terjadi lonjakan kasus positif COVID-19 pada bulan Juni. Hingga 3 Juli 2020, total kasus positif COVID-19 di Kabupaten Pamekasan adalah sebanyak 121 orang dan pada saat itu termasuk dalam kategori wilayah risiko tinggi.
Tujuan: Penelitian dini ini bertujuan untuk menggambarkan pelaksanaan deteksi dan respon COVID-19 di Dinas Kesehatan Kabupaten Pamekasan.
Metode: Penelitian ini dilakukan secara observasional dengan desain penelitian deskriptif.Pengumpulan data diperoleh dari hasil wawancara mendalam kepada satu penanggungjawab surveilans COVID-19 Dinas Kesehatan Kabupaten Pamekasan dan satu petugas surveilans puskesmas yang dipilih secara random sampling. Hasil akan dibandingkan dengan baru, Keputusan Menteri Kesehatan Nomor 247 Tahun 2020.
Hasil: Berdasarkan hasil wawancara dan observasi dilakukan, deteksi dini dan respons COVID-19 di Dinas Kesehatan Kabupaten Pamekasan dilakukan melalui peningkatan kerja, koordinasi pelayanan kesehatan, risiko wilayah, koordinasi pelayanan yang kemungkinan dan konfirmasi, pola kontak, pengiriman spesimen, pengadaan logistik, komunikasi risiko, penyelidikan epidemiologi, pengolahan dan analisis data, serta pencatatan dan pelaporan.Namun, kasus kasus ILI belum dilakukan untuk kasus kasus, pengolahan data belum dilakukan secara rutin, dan pelaporan belum sesuai dengan Kepmenkes 247 tahun 2020.
Kesimpulan: Masih terdapat ketidaksesuaian pelaksanaan deteksi dini dan tanggap COVID-19 di Dinas Kesehatan Kabupaten Pamekasan dengan baru yaitu Kepmenkes 247 tahun 2020 sehingga perlu lebih ditingkatkan dan lebih baru yang ada.
Kata Kunci: COVID-19, Coronavirus, Deteksi dini, Respon
ABSTRACT
Background: Coronavirus disease is a new disease that first appeared in Wuhan, China. The case has spread so widely that it has infected more than 13 million people until July 13, 2020. COVID-19 first reported in Pamekasan District on March 29, 2020. Cases continued to increase, and a surge in COVID-19 cases occurred in June. Until July 3, 2020, the total positive patients of COVID-19 in Pamekasan District were 121 people and at that time included in the high-risk area category.
Objectives: This study aims to describe the early detection and response activities for COVID-19 carried out by the Pamekasan District Health Office.
Methods: This research was conducted observational with a descriptive design. Data collection obtained from in-depth interviews with one person in charge of surveillance for COVID-19 at the Pamekasan District Health Office and one surveillance officer selected by random sampling. The results will be compared with the guidelines, namely the Minister of Health Decree Number 247 of 2020.
Results:Early detection and the response of COVID-19 at the Pamekasan District Health Office is carried out through strengthening networks,coordination with health services facilities, regional risk assessment, monitoring of probable and confirmed cases, contact tracing, specimen delivery, procurement of logistics, risk communication, epidemiological investigations, processing and data analysis, recording and reporting case data. However, ILI case monitoring has not been carried out for case finding, data analysis has not been carried out routinely, and reporting is not in accordance with the Minister of Health Decree 247 of 2020.
Conclusions: The implementation of early detection and response to COVID-19 at the Pamekasan District Health Office is still in conformity with the guidelines, so it needs to be further improved and follow the existing approaches.
Keywords: COVID-19, Coronavirus, Early Detection, Response
Abrams, E. M. dan Greenhawt, M. (2020) ‘Risk Communication During COVID-19', The Journal of Allergy and Clinical Immunology. In Practice, 8(8), pp. 1791–1794. doi: 10.1016/j.jaip.2020.04.012.
CDC (2020) Cases, Data, and Surveillance, Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html (Accessed: 9 August 2020).
CDC (2020) COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity. U.S. Available at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html.
Dinkes Pamekasan (2020) Laporan Harian COVID-19 di Kabupaten Pamekasan. Pamekasan: Dinas Kesehatan Kabupaten Pamekasan.
Djalante, R., Lassa, J., Setiamarga, D., Sudjatma, A., Indrawan, M., Haryanto, B., Mahfud, C., Sabaruddin, M., Djalante, S., Ra, I., Adi, L., Ayu, G., Surtiari, K., dan Warsilah, H. (2020) ‘Review and Analysis of Current Responses to COVID-19 in Indonesia : Period of January to March 2020', Progress in Disaster Science, 6. doi: 10.1016/j.pdisas.2020.100091.
Erkhembayar, R., Dickinson, E., Badarch, D., Narula, I., Thomas, G. N., Ochir, C., dan Manaseki-Holland, S. (2020) ‘Early policy actions and emergency response to the COVID-19 pandemic in Mongolia: experiences and challenges', The Lancet Global Health. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license, (20). doi: 10.1016/s2214-109x(20)30295-3.
Frimpong, J. A., Park, M. M., Amo-Addae, M. P., Adewuyi, P. A., dan Nagbe, T. K. (2017) ‘Detecting, Reporting, and Analysis of Priority Diseases for Routine Public Health Surveillance in Liberia', The Pan African medical journal, 27(Supp 1), p. 9. doi: 10.11604/pamj.supp.2017.27.1.12570.
Groseclose, S. L. dan Buckeridge, D. L. (2017) ‘Public Health Surveillance Systems: Recent Advances in Their Use and Evaluation', Annual Review of Public Health, 38, pp. 57–79. doi: 10.1146/annurev-publhealth-031816-044348.
Jackson, D., Anders, R., Padula, W. V., Daly, J., dan Davidson, P. M. (2020) ‘Vulnerability of Nurse and Physicians with COVID-19: Monitoring and Surveillance Needed', Journal of Clinical Nursing, pp. 1–4. doi: 10.1111/jocn.15347.
Kepmenkes RI (2020) Keputusan Menteri Kesehatan RI Nomor 247 Tahun 2020 Tentang Pedoman Pencegahan dan Pengendalian Coronavirus Disease 2019 (COVID-19). Jakarta.
Mitchell, S. H., Bulger, E. M., Duber, H. C., Greninger, A. L., Ong, T. D., Morris, S. C., Chew, L. D., Haffner, T. M., Sakata, V. L., dan Lynch, J. B. (2020) ‘Western Washington State COVID-19 Experience: Keys to Flattening the Curve and Effective Health System Response', Journal of the American College of Surgeons. doi: 10.1016/j.jamcollsurg.2020.06.006.
Shen, C., Tan, M., Song, X., Zhang, G., Liang, J., Yu, H., dan Wang, C. (2020) ‘Comparative Analysis of Early-Stage Clinical Features Between COVID-19 and Influenza A H1N1 Virus Pneumonia', Frontiers in Public Health, 8, pp. 1–7. doi: 10.3389/fpubh.2020.00206.
Liu, Z., Bing, X., dan Zhi, X. Z. (2020) ‘An Update on The Epidemiological Characteristics of Novel Coronavirus Pneumonia (COVID-19)', Chinese Journal of Epidemiology, 41(2), pp. 139–144. doi: 10.3760/cma.j.issn.0254-6450.2020.02.002.
WHO (2020) Novel Coronavirus – China. Available at: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ (Accessed: 26 June 2020).
WHO (2020) Pertanyaan dan Jawaban: Pelacakan kontak untuk COVID-19, World health Organization. Available at: https://www.who.int/indonesia/news/novel-coronavirus/qa-contact-tracing (Accessed: 8 August 2020).
WHO (2020) WHO Director-General's Opening Remarks At the Media Briefing on COVID-19 - 11 March 2020, WHO Director General's speeches. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (Accessed: 27 June 2020).
Worldometer (2020) Coronavirus Update (Live): COVID-19 Coronavirus Pandemic - Worldometer. Available at: https://www.worldometers.info/coronavirus/ (Accessed: 9 July 2020).
Media Gizi Kesmas by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author(s) to hold the copyright and to retain the publishing right of the article without restrictions.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
3. The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
